SeptiCyte
Manufacturing · Washington, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
425 Pontius Ave N Ste 470, Seattle, Wash...Phone Number
(206) 858-6436Website
www.septicyte.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About SeptiCyte
Immunexpress is a molecular diagnostic company dedicated to developing technology for accurate sepsis diagnosis in patients suspected of having an infection. Their primary product, SeptiCyte RAPID, is an FDA-cleared and CE marked test that provides rapid and reliable sepsis diagnostics by utilizing a patient's immune system biomarkers. This test significantly accelerates the decision-making process for clinicians by delivering actionable results within about an hour, thereby improving patient outcomes. With offices in Seattle and Brisbane, Immunexpress aims to transform sepsis diagnostics and enhance treatment effectiveness across healthcare settings.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is SeptiCyte your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on SeptiCyte recently announced quarterly report
SeptiCyte, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when SeptiCyte launches new products
Website visits: Recent activity has been detected on your website
Click to see if SeptiCyte had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at SeptiCyte
Funding: Get notified immidiatlly once SeptiCyte has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if SeptiCyte has recently received funding, and reach out quickly before it becomes old news!
Check out if SeptiCyte is spiking on competitors!
Recommended Actions
Find VP level buyers at SeptiCyte
Find more new buyers
Compare Similar Companies to SeptiCyte
Compare insights from companies similar to SeptiCyte, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
SeptiCyte
<$5M
11-50
Private
-
-
N/A
Company Profile Activity
Activity Insights
SeptiCyte is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
SeptiCyte is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about SeptiCyte.
SeptiCyte Tech Stack
A closer look at the technologies used by SeptiCyte
SeptiCyte News & Media
Publication in the Journal, Infection, Demonstrates Clinical Utility of SeptiCyte® RAPID for Early Recognition of Sepsis in Patients After Major Abdominal Surgery
SeptiCyte® RAPID results were consistent with retrospective clinical diagnosis of sepsis by blinded experts SEATTLE and BRISBANE, Australia, Dec. 3, 2024 /PRNewswire/ -- Immunexpress, Pty Ltd., a molecular diagnostics company focused on improving outcomes for suspected sepsis patients,...New Publication Further Validates SeptiCyte® RAPID for Disease Severity Assessment and Triaging in COVID-19 Patients with Extensive Lung Injury
SeptiCyte® RAPID accurately measured disease severity in COVID-19 patients, when compared to a CT-scan based reference method SeptiScores™ were unaffected by anti-inflammatory treatments, consistent with SeptiCyte gene involvement in sepsis-related pathways other than the immediate-early...
Read more news
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding SeptiCyte
Sign Up For FreeTo access detailed company insights
Immunexpress is a molecular diagnostic company dedicated to developing technology for accurate sepsis diagnosis in patients suspected of having an infection. Their primary product, SeptiCyte RAPID, is an FDA-cleared and CE marked test that provides rapid and reliable sepsis diagnostics by utilizing a patient's immune system biomarkers. This test si... Read More
